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Abstract:   
Background: Neonatal diarrhea affects nearly 25% of pre-weaned calves. 
Prevention through management practices is the preferable approach to 
control diarrhea. Once calves experience diarrhea, fluids, electrolytes and 
acid-base balance need to be restored. Severe cases of diarrhea should be 
treated with antimicrobials but the need of antimicrobials in mild and 
moderate clinical cases it is still under debate.
Objectives: The objective of this study is to evaluate the efficacy of 
antimicrobial treatments or the comparative efficacy of antimicrobials 
treatments in calves with mild, moderate and severe diarrhea.
Design: The search strategy will be based on population (calves with 
diarrhea), and intervention (antimicrobial therapy). The following data bases 
will be used: Medline, CAB abstracts, Scopus, and Biosis. The outcomes of 
interest will be the occurrence and persistence of clinical signs of diarrhea, 
rate of growth, weight gain, feed efficiency or mortality.
Registration: The protocol has been submitted to SYREAF 12.7.19, and 
eScholarship, University of California (https://escholarship.org/) 12.7.19.  
Amendments from Original Protocol: N/A. 
Funding and Support: Partially support from CDFA Antimicrobial Use 
Stewardship program.
Role of Sponsor or Funder: None.
Introduction
Rationale
Neonatal diarrhea affects nearly 25% of pre-weaned calves. Prevention 
through management practices is the preferable approach to control 
diarrhea. Calves undergoing diarrhea may require treatment. The veterinary 
community agrees that fluids, electrolytes and acid-base balance should be 
restored in diarrheic calves. However, the need of antimicrobials to treat and
prevent diarrhea in calves is still under debate for moderate and mild cases. 
Information about the efficacy of antimicrobials should be obtained from 
randomized controlled studies. At the present multiple antimicrobial drugs 
and regimes are used to treat diarrhea in calves. 
The efficacy of antimicrobial treatment regimens will be evaluated to aid 
veterinarians and dairy producers in their decision making. A systematic 
review will be conducted to identify relevant literature. Network meta-
analysis will be used to combine information from multiple studies and 
compare treatments.
Objectives
The objective of this study is to evaluate the efficacy of antimicrobial 
treatments or the comparative efficacy of antimicrobials in calf diarrhea 
treatments. Only antimicrobials labeled to be use in calf diarrhea in the US 
will be included in the meta-analysis.
Methods
Eligibility Criteria:
Studies will be eligible if they are primary research articles with either a 
negative control (placebo, no treatment) or an active comparator (other 
antimicrobial, a non-antimicrobial treatment). The study population of 
interest are calves less than 6 months of age. 
The outcome of interest is clinical cure risk after treatment (or treatment 
failure). The definition of cure (or failure) will be based on the authors' 
definition and may include mortality, specific signs of disease (i.e. fecal 
consistency, fever), unspecific signs of health disorder (i.e. appetite, 
demeanor), or performance (i.e. growth, weight gain, feed efficiency). 
Studies failing to report random treatment allocation will remain in the study;
however, this will be included as a source of bias and assessed as a source of
heterogeneity. 
Clinical question
Are antimicrobial treatments effective at reducing the persistence (cure) of 
clinical signs of diarrhea compared to absence of antimicrobial treatment or 
alternative non-antimicrobial treatments or other antimicrobial treatments? 
Information Sources: 
The information sources used will include:
Database Interface
Medline Pubmed
CAB Abstracts CAB Direct
Scopus Scopus
Biosis Web of Science
 
The research will be restricted to peer-review manuscripts written in English 
language. Publication date will not be limited. 
Search Strategy:
The search strategy will be based on population (calves with scours/diarrhea 
<6 months of age) and intervention (oral or injectable antimicrobials).  
PRISMA-S  Template (based on v1.0 retrieved from https://osf.io/2ybwn/)
Search Strategy for Effectiveness of Antimicrobials in the Treatment of Neonatal 
Diarrhea in Calves: A protocol for a Systematic Review and Meta-analysis Protocol 
submission in SYREAF (http://www.syreaf.org/contact/)
Databases and Interfaces Searched:
Database Interface Date Coverage Date Searched
Medline Pubmed 1966 to Present 1 July 2019
CAB Abstracts CAB Direct 1972 - Current 1 July 2019
Scopus Scopus 1970 - Current 2 July 2019
Biosis Web of Science 1926 - Current 2 July 2019
Citation Searching And Text Analysis:
Article Citation:
Howarth, J. A., D. R. Cordy, and J. Bittle. "Salmonella bredeney infection of calves and prophylaxis 
with chloromycetin and streptomycin." Journal of the American Veterinary Medical Association 
124.922 (1954): 43-46.
Constable PD. Antimicrobial use in the treatment of calf diarrhea. Journal of veterinary internal 
medicine. 2004 Jan;18(1):8-17.
Mylrea, P. J. (1968). Passage of antibiotics through the digestive tract of normal and scouring calves 
and their effect upon the bacterial flora. Research in veterinary science, 9(1), 5-13.
McLean, D. M., & Bailey, L. F. (1972). The effectiveness of three treatments for scouring in calves. 
Australian Veterinary Journal, 48(6), 336–338.
Glantz, P. J., Kradel, D. C., & Seward, S. A. (1974). Escherichia coli & Salmonella newport in calves: 
efficacy of prophylactic and therapeutic treatment. Veterinary Medicine, Small Animal Clinician : VM,
SAC, 69(1), 77-82 passim.
Bywater, R. J. (1977). Evaluation of an oral glucose-glycine-electrolyte formulation and amoxicillin 
for treatment of diarrhea in calves. American journal of veterinary research, 38(12), 1983.
Daniels, L B, D Fineberg, J M Cockrill, Q Hornsby, H P Peterson, and L Stratton
1977 Use of trimethoprim-sulfadiazine in controlling calf scours. Veterinary medicine, small animal 
clinician : VM, SAC 72(1):93–95.
Palmer, G H, R J Bywater, and M E Francis
1977 Amoxycillin: distribution and clinical efficacy in calves. The Veterinary record 100(23):487–491.
Gupta, A. K., & Baxi, K. K. (1978). Study on the efficacy of antibiotics and furazolidone in the 
treatment of clinical cases of colibacillosis in calves [India]. Indian Veterinary Journal (India).
White, G., Piercy, D. W. T., & Gibbs, H. A. (1981). Use of a calf salmonellosis model to evaluate the 
therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo. 
Research in veterinary science, 31(1), 27-31.
VanDamme, D. (1982). Sulfachlorpyridazine in the treatment of colibacillosis in neonatal calves. 
Bovine Practice, 3(2), 26,28-30.
Rollin, R. E., Mero, K. N., Kozisek, P. B., & Phillips, R. W. (1986). Diarrhea and malabsorption in calves
associated with therapeutic doses of antibiotics: absorptive and clinical changes. American Journal 
of Veterinary Research, 47(5), 987–991.
Process:  Key articles were identified by Principal Investigator and keywords were 
mined by finding references in PubMed, CAB Direct, Scopus, and Biosis.  Keywords 
were collected and compared with keywords already utilized. Yale MeSH analyzer 
was also utilized to compare common Medical Subject Headings across articles.  
Content expert, Noelia Silva Del Rio, was consulted for identification of key 
pathogens and antibiotics currently used in calves.
Limits and Restrictions
Date and Time Period: Based on database coverage.
Language: English
Publication status: Published content only.
Species Included: bovine, neonatal (calves)
Study Design:  Any prospective trial.
Search Filters:
Database Interface Search Filters Applied
Medline Pubmed English
CAB Abstracts CAB Direct English
Scopus Scopus English
Biosis Web of Science English
Full Search Strategy:
Search Database : Pubmed
Search ID Terms (copy and paste) Result
s
#1 
(disease) ("Diarrhea"[Mesh] OR "Gastroenteritis/veterinary"[Mesh] OR "Escherichia 
coli Infections/drug therapy"[Mesh] OR  "Escherichia coli 
Infections/veterinary"[Mesh] OR "Salmonella"[Mesh] OR "Salmonella 
Infections, Animal/drug therapy"[Mesh] OR "Coronavirus, Bovine"[Mesh] 
OR "Rotavirus Infections/veterinary"[Mesh] OR "Cryptosporidiosis"[Mesh] 
OR "Malabsorption Syndromes/veterinary"[Mesh] OR  
“enterobacter”[Mesh] OR “scours”[tiab] OR “scouring”[tiab] OR 
“scour”[tiab] OR Cryptosporidiosis[tiab] OR Cryptosporidioses[tiab] OR 
Cryptosporidium[tiab] OR “Escherichia”[tiab] OR “diarrhea”[tiab] OR 
“Salmonella”[tiab] OR “starvation”[tiab] OR “perfringens”[tiab] OR 
“rotavirus”[tiab] OR “coronavirus”[tiab] OR “Enterobacter”[tiab] OR 
“clostridiales”[tiab] OR “clostridiaceae”[tiab] OR “clostridia”[tiab] OR 
“protozoal”[tiab] OR "protozoa infection"[tiab] OR "protozoa 
infections"[tiab] OR "protozoan infection"[tiab] OR "protozoan 
infections"[tiab] OR protozoiasis[tiab] OR "protozoon infection"[tiab] OR 
"protozoon infections"[tiab] OR “malabsorption”[tiab] )
507,73
7
#2 
(Patient)
“Calf”[tiab] OR “calves”[tiab] 62,249
#3 
(treatmen
t)
“oxytetracycline”[tiab] OR “terramycin”[tiab] OR “hydrotetracycline”[tiab] 
OR “oxyterracin”[tiab] OR “bisolvomycin”[tiab] OR 
“sulfachlorpyridazine”[tiab] OR “sulphachlorpyridazine”[tiab] OR 
“sulfanomides”[tiab] OR “pyridazines”[tiab] OR “antibiotics”[tiab] OR 
“antimicrobials”[tiab] OR “antiinfective”[tiab] OR “anti-infective”[tiab] 
“therapy”[tiab] OR “amoxicillin”[tiab] OR “ampicillin”[tiab] OR 
“penicillin”[tiab] OR “clavulanic”[tiab] OR “clavulanate”[tiab] OR 
“clavulin”[tiab] OR “amox-clav”[tiab] OR “clav”[tiab] OR “amoxiclav”[tiab] 
OR “chlortetracycline”[tiab] OR “aureomycin“[tiab] OR 
“aureomycine“[tiab] OR “biomycin“[tiab] OR “streptomycin”[tiab] OR 
“streptomycine“[tiab] OR “aminoglycoside”[tiab] OR 
“estreptomicina”[tiab] OR “strepto-hefa”[tiab] OR 
“sulphamethylphenasole“[tiab] OR “sulfadimidine“[tiab] OR 
“sulphadimidine“[tiab] OR “sulfamethazine“[tiab] OR 
“sulfachloropyridiazine”[tiab] OR “sulphamezathine”[tiab] OR 
“tetracycline“[tiab] OR “sustamycin”[tiab] OR “achromycin“[tiab] OR 
“tetrabid“[tiab] OR “cephamycin”[tiab] OR “cephalosporins”[tiab] OR 
“procaine”[tiab] OR “neomycin”[tiab] OR “fradiomycin”[tiab] OR 
“chloramphenicol”[tiab] OR “cloranfenicol”[tiab] OR “chloromycetin”[tiab] 
OR “florfenicol”[tiab] OR “florphenicol”[tiab] OR “trihydrate”[tiab] OR 
“aminobenzylpenicillin”[tiab] OR “ks-r1”[tiab] OR “sultamicillin”[tiab] OR 
“sulbactam”[tiab] OR “unasyn”[tiab] OR “ceftiofur”[tiab] OR “naxcel”[tiab]
OR “trimethoprim”[tiab] OR “sulfadiazine”[tiab] OR “ditrim”[tiab] OR 
“tribrissen”[tiab] OR “prophylactic”[tiab] OR 
“sulphamethylphenasole”[tiab] OR “Gentamicin”[tiab] OR “gentavet”[tiab]
OR “genticin”[tiab] OR “gentamycin”[tiab] OR “furazolidone”[tiab] OR 
“nifurazolidone”[tiab] OR “apramycin”[tiab] OR “fluoroquinolone”[tiab] OR 
“enrofloxacin”[tiab] OR “baytril”[tiab] OR “endrofloxacin”[tiab] OR 
“marbofloxacin”[tiab] OR “zeniquin”[tiab] OR “danofloxacin”[tiab] OR 
“advocin”[tiab] OR "Administration, Oral"[Mesh]  OR “Neomycin"[Mesh] OR
"Oxytetracycline"[Mesh] OR "Sulfachlorpyridazine"[Mesh] OR 
"Amoxicillin"[Mesh] OR "Amoxicillin-Potassium Clavulanate 
Combination"[Mesh] OR "Chlortetracycline"[Mesh] OR 
"Streptomycin/veterinary"[Mesh] OR "Sulfamethazine"[Mesh] OR 
"Tetracycline"[Mesh] OR "Penicillin V"[Mesh] OR "Procaine"[Mesh] OR 
"Cephamycins"[Mesh] OR "L 640876" [Supplementary Concept] OR 
"Chloramphenicol"[Mesh] OR "florfenicol" [Supplementary Concept] OR 
"sultamicillin" [Supplementary Concept] OR "ceftiofur" [Supplementary 
Concept] OR "sulfadiazine, trimethoprim drug combination" 
[Supplementary Concept] OR "Gentamicins"[Mesh] OR 
"Sulfonamides"[Mesh] OR "Furazolidone"[Mesh] OR "apramycin" 
[Supplementary Concept] OR "Enrofloxacin"[Mesh] OR "marbofloxacin" 
[Supplementary Concept] OR "danofloxacin" [Supplementary Concept] OR 
"Anti-Infective Agents/veterinary"[Mesh] OR "Electrolytes/therapeutic 
use"[Mesh]
 
63844
8
 
 
#4 #1 AND #2 AND #3 Filter: English 578
 
 
Search Database: CAB Direct
Search ID Terms (copy and paste) Results
#1 
(disease)
Ti:( diarrh* OR scour* OR escherich* OR salmonell* OR enterobact* OR 
clostrid* OR Escherichia OR Salmonella OR Coronavirus OR Rotavirus 
OR Cryptosporidiosis OR Malabsorption OR scours OR scouring OR 
diarrh* OR starvation OR perfringens OR gastroenteritis  OR coronavirus
OR Enterobacter OR clostridiales OR clostridiaceae OR clostridia OR 
protozoal) or od:("Escherichia%20coli" OR "Clostridium" OR 
"Salmonella" or "Clostridium%20perfringens”  OR “Enterobacteriaceae” 
OR “Enterobacteriales” OR “prokaryotes” OR “calf diarrhoea 
rotavirus”  OR “betacoronavirus” OR “norovirus” OR “Eimeria” ) OR 
de: ("salmonellosis" OR “diarrhoea” OR "Escherichia%20infections" OR 
“cryptosporidiosis” OR “Intestinal%20diseases”  )
 
 
 
282,615
#2 
(populatio
n)
Ti:(calf OR calves) OR de: (”calves” or “calf diseases”) 66,381
 
#3 
(therapy)
Ti:(oxytetracycline OR tetracycline OR antibiotic* OR antimicrobial* OR 
antiinfective OR therapy OR sulfachlorpyridazine OR  
sulphachlorpyridazine OR sulfanomide* OR strepto-hefa OR 
sulphamethylphenasole OR sulfadimidine OR sulphadimidine OR 
sulfamethazine OR sulfachloropyridiazine OR sulphamezathine OR clav*
OR gentamycin* OR cephamycin OR cephalosporins OR fluoroquinolone 
OR enrofloxacin OR marbofloxacin OR amox* OR Penicillin OR Ampicillin
OR trimethoprim* OR probiotic OR hydrotetracycline OR oxyterracin OR 
bisolvomycin OR pyridazines OR antibiotic* OR antimicrobial* OR 
antiinfective OR anti-infective OR amox* OR ampicillin OR penicillin OR 
clavul* OR chlortetracycline OR aureomycin* OR biomycin OR  
streptomycin* OR aminoglycoside* OR estreptomicina OR OR 
sulphamethylphenasole OR sulfadimidine OR tetracycline OR 
sustamycin OR achromycin OR tetrabid OR procaine OR neomycin OR 
fradiomycin OR chloramphenicol OR cloranfenicol OR kloramfenikol OR 
chloromycetin OR kloramfenikol OR florfenicol OR florphenicol OR 
trihydrate OR aminobenzylpenicillin OR ks-r1 OR sultamicillin OR 
sulbactam OR unasyn OR ceftiofur OR naxcel OR U-24769 OR 
trimethoprim   OR ditrim OR tribrissen OR prophylactic OR 
sulphamethylphenasole OR Gentam* OR furazolidone OR nifurazolidone
OR apramycin OR fluoroquinolone OR enrofloxacin OR baytril OR 
endrofloxacin OR marbofloxacin OR zeniquin OR danofloxacin OR 
advocin OR Neomycin OR L640876 OR  ceftiofur OR Furazolidone OR 
“milk replacer” ) OR de:( “animal%20feeding" or "antibiotics" or 
"dihydrostreptomycin" OR “spectinomycin”  OR “antibiotics” OR “oral 
administration” OR “prophylaxis” OR “streptomycin” OR 
“aminoglycoside” OR  “amoxicillin” OR “ampicillin” OR “antiinfective
%20agents” OR “beta-lactam%20antibiotics” OR “ceftiofur” OR  
“cephalosporins” OR “clavulanic acid” OR “penicillins” OR 
“tetracyclines” OR “chlortetracycline” OR "milk%20substitutes" OR 
"treatment" OR "substitutes" OR "electrolytes" OR "sulfadiazine" OR 
"trimethoprim" OR "Drug therapy" OR "Antibacterial%20agents" OR 
"fluoroquinolone%20antibiotics" OR "metronidazole" OR "drug
%20combinations" OR "furazolidone" OR "Chloramphenicol" OR 
"Neomycin" OR "sulfadiazine" OR "Sulfonamides" OR "trimethoprim" OR
"beta-lactam%20antibiotics" OR "aminoglycoside%20antibiotics" OR 
"Tetracyclines” OR “antibacterial%20agents” OR “therapeutic
%20agents” OR “therapeutic%20diets”)
 
622,664
#4 La: English 8,146,59
0
#5 #1 AND #2 AND #3 AND #4 1,717
 
 
Search Database: Scopus
Search 
ID
Terms (copy and paste) Results
#1 (TITL-ABS-KEY (diarrh* OR scour* OR gastroenteritis OR escherich* OR 
salmonell* OR enterobact* OR clostrid* OR Escherichia OR Salmonella 
OR Coronavirus OR Rotavirus OR Cryptosporidiosis OR Malabsorption OR
starvation OR perfringens OR coronavirus OR Enterobacter OR 
clostridiales OR protozoal))
1,097,48
8
#2 (Title(Calf OR Calves)) 30,691
#3 (TITL-ABS-KEY(oxytetracycline OR tetracycline OR antibiotic* OR 
antimicrobial* OR antiinfective OR therapy OR sulphamethylphenasole 
OR sulfadimidine OR sulphamethylphenasole OR sulfadimidine OR 
sulfanomide* OR strepto-hefa OR sulphamethylphenasole OR 
sulfadimidine OR sulphadimidine OR sulfamethazine OR 
sulfachloropyridiazine OR sulphamezathine OR clav* OR gentamycin* OR
cephamycin OR cephalosporin* OR fluoroquinolone OR enrofloxacin OR 
marbofloxacin OR amox* OR Penicillin* OR Ampicillin* OR trim* OR 
therapy OR probiotic OR hydrotetracycline OR oxyterracin OR 
bisolvomycin OR pyridazines OR anti-infective OR chlortetracycline OR 
aureomycin* OR biomycin OR  streptomycin* OR aminoglycoside* OR 
estreptomicina OR sustamycin OR achromycin OR tetrabid OR procaine 
OR neomycin OR fradiomycin OR chloramphenicol OR cloranfenicol OR 
kloramfenikol OR chloromycetin OR kloramfenikol OR florfenicol OR 
florphenicol OR trihydrate OR aminobenzylpenicillin OR ks-r1 OR 
sultamicillin OR sulbactam OR unasyn OR ceftiofur OR naxcel OR U-
24769 OR trimethoprim   OR ditrim OR tribrissen OR prophylactic OR 
sulphamethylphenasole OR Gentam* OR furazolidone OR nifurazolidone 
OR apramycin OR fluoroquinolone OR baytril OR endrofloxacin OR 
zeniquin OR danofloxacin OR advocin OR Neomycin OR L640876 OR  
ceftiofur OR Furazolidone OR {milk replacer} )
5,659,88
7
#4 Language (English) 64,418,5
16
#1 AND 
#2 AND 
#3 AND 
#4
 992
 
Search Database: BIOSIS
Searc
h ID
Terms (copy and paste) Results
#1 (Ti=(diarrh* OR scour* OR escherich* OR salmonell* OR enterobact* OR 
clostrid*  OR gastroenteritis OR Escherichia OR Salmonella OR Coronavirus 
OR Rotavirus OR Cryptosporidiosis OR Malabsorption OR starvation OR 
perfringens OR gastroenteritis OR coronavirus OR Enterobacter OR 
clostridiales OR protozoal) AND LANGUAGE: (English)
251,111
#2 Ti=calves OR calf AND LANGUAGE: (English) 33,207
#3 Ti=(oxytetracycline OR tetracycline OR antibiotic* OR antimicrobial* OR 
antiinfective OR therapy OR sulpha* OR sulfa* OR clav* OR gent* OR cepha* 
OR fluoroquinolone OR enrofloxacin OR marbofloxacin OR amox* OR Pen* OR
Amp* OR trim* OR therapy OR probiotic OR hydrotetracycline OR oxyterracin
OR bisolvomycin OR pyridazines OR anti-infective OR chlortetracycline OR 
aureo* OR biomycin OR  streptomycin* OR aminoglycoside* OR 
estreptomicina OR sustamycin OR achromycin OR tetrabid OR procaine OR 
neomycin OR fradiomycin OR chlor* OR clor* OR kloramfenikol OR florfenicol 
OR florphenicol OR trihydrate OR aminobenzylpenicillin OR ks-r1 OR 
sultamicillin OR sulbactam OR unasyn OR ceftiofur OR naxcel OR U-24769 OR
trimethoprim   OR ditrim OR tribrissen OR prophylactic OR 
sulphamethylphenasole OR Gentam* OR furazolidone OR nifurazolidone OR 
apramycin OR fluoroquinolone OR baytril OR endrofloxacin OR zeniquin OR 
danofloxacin OR advocin OR Neomycin OR L640876 OR  ceftiofur OR 
Furazolidone OR “milk replacer”) AND LANGUAGE: (English)
1,225,5
76
#4 #1 AND #2 AND #3 221
Search Designers:  
Erik Fausak was the librarian who designed the search strategy with input and 
reference citation list from content expert, Dr. Noelia Silva Del Rio . 
Peer Review:
Two peer reviewers examined CAB and Pubmed search strategy, gave input that 
was applied to search strategy.  Deanna Johnson and Megan Van Noord.
Total 
Records
Total Records 
after 
deduplication
Deduplication software/methodology
3,868 2,707 Mendeley, matches across fields and gives
confidence.  All suggested merges were 
approved.
Study Records:
Studies will be exported from Mendeley (Mendeley Ltd.) into a systematic 
review management software (DistillerSR, Evidence Partners Inc.; Ottawa, 
ON, Canada). Duplicates will be deleted.
Selection Process:
The process to select relevant records will include the following steps:
Title screening:
a. Does the title describe the use of an antimicrobial treatment?
b. Does the title indicate cattle as the subject of study?
Abstract screening:
c. Does the study describe a controlled trial?
d. Does the abstract describe a study of diarrhea in calves?
e. Does the study describe one or more intervention groups of an 
antimicrobial treatment regimen?   
f. Are antimicrobial treatments given after the diagnosis of diarrhea?
g. Does the study describe an outcome related to clinical cure or 
performance (i.e. growth)?
If the answers above are yes then, full manuscripts will be evaluated. A 
record will only need one reviewer to indicate it is relevant to be forwarded 
to the full-text relevance screening. Excluded records will be evaluated by 
two reviewers. If there is no consensus between the two reviewers, a third 
reviewer will be consulted.
Data Collection Process:  
Citation searches will be collected using a citation management software 
(Mendely Ltd.). Eligible publications after title/abstract screening will be 
acquired as full manuscripts with the assistance of the UC Davis librarian. 
Relevant data will be extracted into a spreadsheet form (Excel 2010, 
Microsoft Corp., Redmond, WA).
The spreadsheet form will capture the following information:
 Population: location, year, calves age, weight, and breed. 
 Eligibility criteria based on author’s definition (i.e. scours, fever, 
unspecific signs of health disorder). 
 Individuals evaluating clinical signs of health disorder prior to 
enrollment (researcher / owner / veterinarian / other). 
 Individuals applying treatments (researcher / owner / veterinarian / 
other) 
 Individuals evaluating clinical signs of health disorder after treatment 
(researcher / owner / veterinarian / other). 
 Description of treatment protocol implemented (drug type, dose, route,
frequency).
 Definition of treatment effectiveness (cure) based on author’s 
definition (i.e. fecal score, fever).
 Time when outcomes were measured relative to treatment onset.
 Intervention of interest and the comparator group(s) (i.e. type of drug, 
route, dose, frequency).
 Results of binary (i.e. mortality and clinical cure) and continuous (i.e. 
time to cure, growth, intake and feed efficiency) outcomes will be 
extracted including: sample sizes, raw data or relative measure 
(RR,OR), effect size, variation of effect size, other variables controlled 
in the analysis such as age, breed, season or other.
The possible metrics will be extracted following the order below: 
1. Adjusted summary effect size. 
2. Unadjusted summary effect size. 
3. Arm level risk of the outcome or mean of the outcome. 
4. Variance components.
Risk of bias in Individual Studies:
Cochrane ROB 2.0 tool will be modified to evaluate the risk of bias (Higgins 
et al., 2016). https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-
tool. 
1. Randomization process: It is expected that some studies will not report
randomization. Thus, randomization without describing the allocation 
approach will not be considered a risk of bias. 
2. Deviations from intended interventions: Reasons for trial exclusion 
after intervention will be evaluated. 
3. Missing outcome data: Bias due to loss to follow-up data will be 
evaluated, but it might not be relevant in randomized calf trials. 
4. Measurement of the outcome: The outcome assessors might not be 
blinded to interventions but if the outcome is unlikely to be biased (i.e. 
temperature-fever) it will be listed as a low risk of bias.
5. Bias in selection of the reported results: Time to event (clinical cure), 
and differences in proportions of calves across studies.
Data Synthesis:
Network meta-analysis. Based on the approach described by NICE 
Decision Support Unit, a generalized linear modeling framework with a logit 
link will be use for the binary outcomes (clinical cure and mortality; Dias et 
al., 2014). The software of choice to perform the data analysis with be Stata 
(Statacorp LP; College Station, TX). 
Meta-bias(es): Publication bias in the network of evidence will be carried 
out as described by Mavridis et al. (2014) and presented as a funnel plot.
Confidence in Cumulative Evidence: The quality of evidence for each 
outcome will be assessed using GRADE (GRADE, 2015, Puhan et al., 2014), 
while considering the nature of the network meta-analysis (Jansen et al., 
2011). If feasible, we will use the CINeMA (Confidence In Network Meta-
Analysis) web-based application platform, to evaluate the impact of risk of 
bias on study results. 
Discussion:
The proposed systematic review and network meta-analysis will summarize 
the current evidence regarding the efficacy of antimicrobials used for the 
treatment of diarrhea in calves. It is anticipated that results will assist 
producers and veterinarians to make evidence-based decisions when 
treating calves. Lastly, the proposed systematic review will assist 
researchers to identify current gaps in knowledge related to the efficacy of 
antimicrobials to treat diarrhea in calves.
References:
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